Researcher urges caution using remdesivir to treat COVID-19 medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Bingfang Yan is a professor at the University of Cincinnati s James L. Winkle College of Pharmacy. Yan s UC laboratory studies how drugs are metabolized in the body to see if. view more
Credit: University of Cincinnati
While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.
Research at the University of Cincinnati, however, contends that this antiviral drug is being used too indiscriminately when treating patients hospitalized with the virus. The study is published in the journal